Centauri Therapeutics' Unattributed - II Round

Centauri Therapeutics raised a round of funding on February 20, 2017. Investors include Horizon Discovery.

Centauri Therapeutics is a biotechnology company focused on the discovery and development of novel molecules targeting life-threatening diseases, such as infectious diseases and cancer.…

Articles about Centauri Therapeutics' Unattributed - II Round: